Post-marketing surveillance of adverse events following measles, mumps, rubella and varicella (MMRV) vaccine: retrospecive study in apulia region (ITALY), 2009-2017

Since 2006, some Italian Regions introduced the active offer of measles, mumps, rubella, and varicella (MMRV) vaccine for all newborns during the second years of life. In 2011, Italian Drug Authority (AIFA) recommended the discontinuation of the MMRV use for an increased risk of febrile seizures fol...

Descripción completa

Detalles Bibliográficos
Autores principales: Stefanizzi, Pasquale, De Nitto, Sara, Patano, Francesco, Bianchi, Francesco Paolo, Ferorelli, Davide, Stella, Paolo, Ancona, Domenica, Bavaro, Vito, Tafuri, Silvio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2020
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7482746/
https://www.ncbi.nlm.nih.gov/pubmed/32040350
http://dx.doi.org/10.1080/21645515.2019.1704124

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7482746/
https://www.ncbi.nlm.nih.gov/pubmed/32040350
http://dx.doi.org/10.1080/21645515.2019.1704124

Ejemplares similares